Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam
Journal of Viral Hepatitis 32(11) (2025)
Didier Laureillard; Nguyen Thanh Binh; Vu Hai Vinh; Tran Thi Hong; Catherine Quillet; Nham Thi Tuyet Thanh; Roselyne Vallo; Bach Thi Nhu Quynh; Jean Pierre Moles; Khuat Thi Hai Oanh; Duong Thi Huong; Delphine Rapoud; Jonathan Feelemyer; Laurent Michel; Peter Vickerman; Hannah Fraser; Laurence Weiss; Maud Lemoine; Karine Lacombe; Don Des Jarlais; Pham Minh Khue; Nicolas Nagot
Highly sensitive and selective β-Ni(OH)2@CNTs modified electrode for detection of Anti-Hepatitis C
Microchemical Journal 215 (2025)
Melad Lotfallah Adolf; Mahmoud A. Hefnawy; Shymaa S. Medany; Eman Yossri Frag
Efficacy and safety of anti-Hepatitis C virus regimens containing daclatasvir: a systematic review and meta-analysis from Egypt
Egyptian Liver Journal 15(1) (2025)
Muhammad Abdel-Gawad; Amro M. Hassan; Ahmed Q. Mohammed; Ashraf M. Al Kabeer; Eman Marwan; Mohamed M. Abd Elnaser; Mohamed El-Kassas
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
Annals of Hepatology 16(2) (2017)
Mohammad Saeid Rezaee-Zavareh; Khashayar Hesamizadeh; Bita Behnava; Seyed Moayed Alavian; Mohammad Gholami-Fesharaki; Heidar Sharafi
Perspectives on NASH Histology: Cellular Ballooning
Annals of Hepatology 16(2) (2017)
Stephen Caldwell; Carolin Lackner
Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial
EBioMedicine 21 (2017)
Mostafa Yakoot; Alaa M. Abdo; Siham Abdel-Rehim; Sherine Helmy
Letter: the efficacy of interferon‐free regimens in HCV‐related Child C cirrhosis needs careful interpretation
Alimentary Pharmacology & Therapeutics 46(1) (2017)
M. S. Rezaee‐Zavareh; S. M. Alavian
Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017
Hepatitis Monthly 17(11) (2017)
Seyed Moayed Alavian; Heidar Sharafi
Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis
Hepatitis Monthly 17(6) (2017)
Mohammad Saeid Rezaee-Zavareh; Khashayar Hesamizadeh; Heidar Sharafi; Seyed Moayed Alavian
The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3
Hepatitis Monthly 17(1) (2016)
Shahin Merat; Amir Houshang Sharifi; Arghavan Haj-Sheykholeslami; Hossein Poustchi; Babak Fattahi; Alireza Nateghi-Baygi; Seyed Moayed Alavian; Reza Malekzadeh
Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
Digestive Diseases and Sciences 66(4) (2020)
Man-Fung Yuen; Sze-Hang Liu; Wai-Kay Seto; Lung-Yi Mak; Shelby L. Corman; Danny C. Hsu; Mary Y. K. Lee; Tsz K. Khan; Amy Puenpatom
Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin
European Journal of Chemistry 10(4) (2019)
Maha Mahmoud Abou El-Alamin; Maha Abd Elrahman Sultan; Maha Hegazy; Alastair William Wark; Marwa Mohamed Azab
SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial
Clinical Infectious Diseases 70(10) (2019)
Shahin Merat; Shahin Merat; Amir-Houshang Sharifi; Hossein Poustchi; Eskandar Hajiani; Abdolsamad Gharavi; Jalal Karimi; Fariborz Mansour-Ghanaei; Mohammad-Reza Fattahi; Lida Ahmadi; Mohammad-Hossein Somi; Hamid Kalantari; Mohammad-Reza Ghadir; Farshad Sheikhesmaeili; Nadieh Baniasadi; Masoudreza Sohrabi; Seyedhamid Moosavy; Masood Ziaee; Mohammad-Javad Zahedi; Marjan Mokhtare; Shahnaz Sali; Babak Sayad; Behrooz Afshar; Alireza Bakhshipour; Abazar Parsi; Afsaneh Sharifian; Taghi Amiriani; Zeinab Malekzadeh; Dorsa Merat; Azita Ganji; Fereidoun Rahmani-Samani; Raika Jamali; Masoomeh Sofian; Mohammad Ghezlou; Amir Ali Sohrabpour; Ladan Goshayeshi; Seyed-Mohammad Valizadeh-Toosi; Layli Eslami; Iradj Maleki; Ahmad Hormati; Ali-Akbar Shayesteh; Elahe Shayesteh; Alireza Norouzi; Zahra Abna; Alireza Janbakhsh; Hafez Fakheri; Mohammad Minakari; Hossein Sardarian; Adel Fallah Ghajary; Mojtaba Fattahi-Abdizadeh; Maryam Latifnia; Fatemeh Roozbeh; Shahram Agah; Saba Fakhrieh-Asl; Alireza Nateghi-Baygi; Babak Fattahi; Helia Nateghi-Baygi; Andrew Hill; Reza Malekzadeh
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
DARU Journal of Pharmaceutical Sciences 25(1) (2017)
Fardin Dolatimehr; Hamidreza Karimi-Sari; Mohammad Saeid Rezaee-Zavareh; Seyed Moayed Alavian; Bita Behnava; Mohammad Gholami-Fesharaki; Heidar Sharafi
Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia
Journal of Medical Virology 91(3) (2018)
Arezoo Khosravi; Hamidreza Karimi‐Sari; Mahdi Abedi‐Andani; Bita Behnava; Ali Namvar; Ali Anvar; Seyed Moayed Alavian
Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’
European Journal of Gastroenterology & Hepatology 30(7) (2018)
Seyed M. Alavian; Heidar Sharafi
Research progress on the direct antiviral drugs for hepatitis C virus
BioScience Trends 11(1) (2017)
Jianjun Gao; Chuanxia Ju